Abstract
Supratentorial primitive neuroectodermal tumor (sPNET) only represents 2.5–3% of childhood brain tumors. It has a worse prognosis than its posterior fossa counterpart and a different molecular signature has been demonstrated. The mainstay of therapy is gross total resection followed by adjuvant therapy that is age dependant, in older children this involves craniospinal radiation and chemotherapy, in the infant different approaches to minimize radiation have been attempted. Prognosis is variable between 5 and 30% 5 year survival, dependent on the child’s age, the presence of dissemination at diagnosis and the treatment options available.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abeloff M (2008) Cancers of the CNS. Abeloff’s clinical oncology, 4th edn, Ch 70. Elsevier, Churchill Livingstone
Albright AL, Wisoff JH, Zeltzer P, Boyett J, Rorke LB, Stanley P, Geyer JR, Milstein JM (1995) Prognostic factors in children with supratentorial (nonpineal) primitive neuroectodermal tumors. A neurosurgical perspective from the Children’s Cancer Group. Pediatr Neurosurg 22:1–7
Arsic D, Cameron V, Ellmers L, Quan QB, Keenan J, Beasley S (2004) Adriamycin disruption of the Shh-Gli pathway is associated with abnormalities of foregut development. J Pediatr Surg 39:1747–1753
Bajaj A, Bajaj SK, Bajaj N (2007) Bilateral retinoblastoma in early infancy: a case report. Kathmandu Univ Med J 5:550–551
Burnett ME, White EC, Sih S, von Haken MS, Cogen PH (1997) Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system. Cancer Genet Cytogenet 97:25–31
Dai AI, Backstrom JW, Burger PC, Duffner PK (2003) Supratentorial primitive neuroectodermal tumors of infancy: clinical and radiologic findings. Pediatr Neurol 29:430–434
Dirks PB, Harris L, Hoffman HJ, Humphreys RP, Drake JM, Rutka JT (1996) Supratentorial primitive neuroectodermal tumors in children. J Neurooncol 29:75–84
Dunkel IJ, Jubran RF, Gururangan S, Chantada GL, Finlay JL, Goldman S, Khakoo Y, Obrein JM, Orjuela M, Rodriguez-Galindo C, Souweidane MM, Abramson DH (2010) Trilateral retinoblastoma: potentially curable with intensive chemotherapy. Pediatr Blood Cancer 54:384–387
Durkin ME, Yuan BZ, Zhou X, Zimonjic DB, Lowy DR, Thorgeirsson SS, Popescu NC (2007) DLC-1:a Rho GTPase-activating protein and tumour suppressor. J Cell Mol Med 11:1185–1207
Fangusaro J, Finlay J, Sposto R, Ji L, Saly M, Zacharoulis S, Asgharzadeh S, Abromowitch M, Olshefski R, Halpern S, Dubowy R, Comito M, Diez B, Kellie S, Hukin J, Rosenbulm M, Dunkel I, Miller D, Allen J, Gardner S (2008) Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience. Pediatr Blood Cancer 50:312–318
Farrell CJ, Plotkin SR (2007) Genetic causes of brain tumors: neurofibromatosis, tuberous sclerosis, von Hippel-Lindau, and other syndromes. Neurol Clin 25:925–946
Girschick HJ, Klein R, Scheurlen WG, Kuhl J (2001) Cytogenetic and histopathologic studies of congenital supratentorial primitive neuroectodermal tumors: a case report. Pathol Oncol Res 7:67–71
Jakacki RI (1999) Pineal and nonpineal supratentorial primitive neuroectodermal tumors. Childs Nerv Syst 15:586–591
Johnston DL, Keene DL, Lafay-Cousin L, Steinbok P, Sung L, Carret AS, Crooks B, Strother D, Wilson B, Odame I, Eisenstat D, Mpofu C, Zelcer S, Huang A, Bouffet E (2008) Supratentorial primitive neuroectodermal tumors: a Canadian pediatric brain tumor consortium report. J Neurooncol 86:101–108
Kivelam T (1999) Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J ClinOncol 17:1829–1837
Klisch J, Husstedt H, Hennings S, von Velthoven V, Pagenstecher A, Schumacher M (2000) Supratentorial primitive neuroectodermal tumours: diffusion-weighted MRI. Neuroradiology 42:393–398
Kuhn SA, Hanisch UK, Ebmeier K, Beetz C, Brodhun M, Reichart R, Ewald C, Deufel T, Kalff R (2007) A paediatric supratentorial primitive neuroectodermal tumour associated with malignant astrocytic transformation and a clonal origin of both components. Neurosurg Rev 30:143–149
Li MH, Bouffet E, Hawkins CE, Squire JA, Huang A (2005) Molecular genetics of supratentorial primitive neuroectodermal tumors and pineoblastoma. Neurosurg Focus 19:E3
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109
McBride SM, Daganzo SM, Banerjee A, Gupta N, Lamborn KR, Prados MD, Berger MS, Wara WM, Haas-Kogan DA (2008) Radiation is an important component of multimodality therapy for pediatric non-pineal supratentorial primitive neuroectodermal tumors. Int J Radiat Oncol 72:1319–1323
Mueller S, Chang S (2009) Pediatric brain tumors: current treatment strategies and future therapeutic approaches. Neurotherapeutics 6:570–586
Pang J, Chang Q, Chung YF, Teo JG, Poon WS, Zhou LF, Kong X, Ng HK (2005) Epigenetic inactivation of DLC-1 in supratentorial primtive neuroectodermal tumor. Human Pathol 36:36–43
Paulino AC (1999) Trilateral retinoblastoma: is the location of the intracranial tumor important? Cancer 86:135–141
Pelengaris S, Khan M, Evan G (2002) c-MYC: more than just a matter of life and death. Nat Rev Cancer 2:764–776
Pizer BL, Weston CL, Robinson KJ, Ellison DW, Ironside J, Saran F, Lashford LS, Tait D, Lucraft H, Walker DA (2006) Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study. Eur J Cancer 42:1120–1128
Plum F, Posner JB (1980) Structural causes of stupor and coma. The diagnosis of stupor and coma, 3rd edn, Ch 3: 93. F.A. Davis Company, Philadelphia
Siffert J, Allen JC (1997) Medulloblastoma. J Neuro-Oncol 24(68):181–209
Strother D, Ashley D, Kellie SJ, Patel A, Jones-Wallace D, Thompson S, Heideman R, Benaim E, Krance R, Bowman L, Gajjar A (2001) Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study. J Clin Oncol 19:2696–2704
Sung KW, Yoo KH, Cho EJ, Koo HH, Lim do H, Shin HJ, Ahn SD, Ra YS, Choi ES, Ghim TT (2007) High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor. Pediatr Blood Cancer 48:408–415
Timmermann B, Kortmann RD, Kuhl J, Meisner C, Dieckmann K, Pietsch T, Bamberg M (2002) Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91. J Clin Oncol 20:842–849
Timmermann B, Kortmann RD, Kuhl J, Rutkowski S, Meisner C, Pietsch T, Deinlein F, Urban C, Warmuth-Metz M, Bamberg M (2006) Role of radiotherapy in supratentorial primitive neuroectodermal tumor in young children: results of the German HIT-SKK87 and HIT-SKK92 trials. J Clin Oncol 24:1554–1560
Yang HJ, Nam DH, Wang KC, Kim YM, Chi JG, Cho BK (1999) Supratentorial primitive neuroectodermal tumor in children: clinical features, treatment outcome and prognostic factors. Childs Nerv Syst 15:377–383
Zurawel RH, Allen C, Chiappa S, Cato W, Biegel J, Cogen P, de Sauvage F, Raffel C (2000) Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma. Genes Chromosome Cancer 27:44–51
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Singh, M., Hukin, J. (2012). Supratentorial Primitive Neuroectodermal Tumors. In: Hayat, M. (eds) Tumors of the Central Nervous System, Volume 4. Tumors of the Central Nervous System, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-1706-0_2
Download citation
DOI: https://doi.org/10.1007/978-94-007-1706-0_2
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-1705-3
Online ISBN: 978-94-007-1706-0
eBook Packages: MedicineMedicine (R0)